Anti-NMDA receptor encephalitis surgery: Difference between revisions

Jump to navigation Jump to search
 
(2 intermediate revisions by the same user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Anti-NMDA receptor encephalitis}}
{{Anti-NMDA receptor encephalitis}}
{{CMG}}
{{CMG}} AE {{DMakkar}}


==Overview==
==Overview==
Surgery plays a crucial role in the treatment of anti-NMDA encephalitis when an associated tumor, typically an ovarian teratoma, is present. Tumor removal can improve prognosis, reduce relapse risk, and enhance response to immunotherapy. A multidisciplinary approach is essential for optimal patient management.


==Surgery==
==Surgery==
*Surgery is primarily considered in the treatment of anti-NMDA encephalitis when there is an associated tumor, most commonly an ovarian teratoma.
*The removal of the tumor is important as it can contribute to the generation of antibodies causing the encephalitis.
*Surgery can improve the patient's overall prognosis and reduce the risk of relapse.
*Surgical removal of the tumor may lead to a more rapid resolution of symptoms and better response to immunotherapy.
However, in cases without an associated tumor, surgery alone is not a standard treatment for anti-NMDA encephalitis, and immunotherapy remains the mainstay of treatment.
*The decision to proceed with surgery is made on a case-by-case basis, taking into consideration various factors such as the presence and type of tumor, the patient's overall health, and the severity of neurological symptoms.
*A multidisciplinary approach involving neurologists, neurosurgeons, and oncologists is crucial to ensure optimal management and outcomes for patients with anti-NMDA encephalitis.


==References==
==References==

Latest revision as of 17:06, 13 May 2023

Anti-NMDA receptor encephalitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Anti-NMDA receptor encephalitis from Other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications, and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Anti-NMDA receptor encephalitis surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Anti-NMDA receptor encephalitis surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Anti-NMDA receptor encephalitis surgery

CDC on Anti-NMDA receptor encephalitis surgery

Anti-NMDA receptor encephalitis surgery in the news

Blogs on Anti-NMDA receptor encephalitis surgery

Directions to Hospitals Treating Anti-NMDA receptor encephalitis

Risk calculators and risk factors for Anti-NMDA receptor encephalitis surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] AE Dheeraj Makkar, M.D.[2]

Overview

Surgery plays a crucial role in the treatment of anti-NMDA encephalitis when an associated tumor, typically an ovarian teratoma, is present. Tumor removal can improve prognosis, reduce relapse risk, and enhance response to immunotherapy. A multidisciplinary approach is essential for optimal patient management.

Surgery

  • Surgery is primarily considered in the treatment of anti-NMDA encephalitis when there is an associated tumor, most commonly an ovarian teratoma.
  • The removal of the tumor is important as it can contribute to the generation of antibodies causing the encephalitis.
  • Surgery can improve the patient's overall prognosis and reduce the risk of relapse.
  • Surgical removal of the tumor may lead to a more rapid resolution of symptoms and better response to immunotherapy.

However, in cases without an associated tumor, surgery alone is not a standard treatment for anti-NMDA encephalitis, and immunotherapy remains the mainstay of treatment.

  • The decision to proceed with surgery is made on a case-by-case basis, taking into consideration various factors such as the presence and type of tumor, the patient's overall health, and the severity of neurological symptoms.
  • A multidisciplinary approach involving neurologists, neurosurgeons, and oncologists is crucial to ensure optimal management and outcomes for patients with anti-NMDA encephalitis.

References

[1] Template:WH Template:WS

  1. Delangle R, Demeret S, Canlorbe G, Chelon L, Belghiti J, Gonthier C; et al. (2020). "Anti-NMDA receptor encephalitis associated with ovarian tumor: the gynecologist point of view". Arch Gynecol Obstet. 302 (2): 315–320. doi:10.1007/s00404-020-05645-9. PMID 32556515 Check |pmid= value (help).